SECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549

---

FORM 10-QSB

---

Quarterly Report Under Section 13 or 15 (d)
of the Securities Exchange Act of 1934

For the Quarter
Ended March 31, 2006     Commission File No. 0-9996

---

|                                                        
|--------------------------------------------------------
|DOTRONIX,
  INC.                                        
|(Exact name of registrant
  as specified in its charter)

|                                  |  |                    
|--------------------------------- |  | -------------------
|Minnesota                         |  | 41-1387074         
|(State or other
  jurisdiction of |  | (I.R.S. Employer   
|incorporation or
  organization)  |  | Identification No.)

|                                            
|--------------------------------------------
|9372 Creekwood Drive, Eden Prairie, MN 55347
|(Address of principal executive offices)    
|                                            
|715-359-6373                                
|(Issuers telephone number)                 

---

Indicate by check mark whether the registrant (1) has
filed all reports required to be filed by section 13 or 15 (d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days.

Yes   x No   o

Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act):      Yes   x      No   o

Indicate the number of shares outstanding of each of
the issuers classes of common stock as of the latest practicable date.

|                        |  |                               | 
|----------------------- |  | ----------------------------- | 
|Class                   |  | Outstanding at April
21, 2006 | 
|                        |  |                               | 
|Common stock, par value |  | 8,002,427 shares              | 
|$.05 per share          |  |                               | 

Transitional Small Business Disclosure Format (Check
One)      Yes   o
      No   x





---



DOTRONIX, INC.
INDEX

|                                 |           |                                                                                         |                           
|-------------------------------- | --------- | --------------------------------------------------------------------------------------- | --------------------------
|Part
  I - Financial Information
|                                 |           |                                                                                         |                           
|                                 | Item 1.   | Condensed Financial
  Statements                                                       
|                                 |           |                                                                                         |                           
|                                 |           |                                                                                         | Balance Sheets            
|                                 |           |                                                                                         |                           
|                                 |           |                                                                                         | Statements of
  Operations
|                                 |           |                                                                                         |                           
|                                 |           |                                                                                         | Statements of Cash
  Flows
|                                 |           |                                                                                        
|                                 |           | Notes to Condensed
  Financial Statements                                              
|                                 |           |                                                                                        
|                                 | Item 2.   | Managements
  Discussion and Analysis of Financial Condition and Results of Operations
|                                 |           |                                                                                        
|                                 | Item 3.   | Controls and
  Procedures                                                              
|                                
|Part II - Other
  Information   
|                                 |           |                                                                                        
|                                 | Item
  5. | Other
  Information                                                                    
|                                 |           |                                                                                        
|                                 | Item 6.   | Exhibits                                                                               

2

---



PART I. FINANCIAL INFORMATIONITEM 1. FINANCIAL STATEMENTS

DOTRONIX,
INC.CONDENSED BALANCE SHEETS

|                                                                                                                                    |  |                 |             |              |   |             |  
|----------------------------------------------------------------------------------------------------------------------------------- |  | --------------- | ----------- | ------------ | - | ----------- | -
|                                                                                                                                    |  | March 31
  2006 |             | June 30 2005 |  
|                                                                                                                                    |  |                 |             |              |  
|                                                                                                                                    |  | (UNAUDITED)     |             |              |  
|ASSETS:                                                                                                                             |  |                 |             |              |   |             |  
|CURRENT ASSETS:                                                                                                                     |  |                 |             |              |   |             |  
|Cash                                                                                                                                |  | $               | 5,046       |              | $ | 18,295      |  
|Accounts receivable, less allowance for
  doubtful accounts of $0 and $1,000, respectively                                          |  |                 |            |              |   | 61,812      |  
|Inventories                                                                                                                         |  |                 |            |              |   | 16,450      |  
|Prepaid expenses                                                                                                                    |  |                 |            |              |   | 18,652      |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|TOTAL CURRENT ASSETS                                                                                                                |  |                 | 5,046       |              |   | 115,209     |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|PROPERTY AND EQUIPMENT                                                                                                              |  |                 |            |              |   | 43,566      |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|TOTAL ASSETS                                                                                                                        |  | $               | 5,046       |              | $ | 158,775     |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|LIABILITIES AND STOCKHOLDERS DEFICIT:                                                                                              |  |                 |             |              |   |             |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|CURRENT LIABILITIES:                                                                                                                |  |                 |             |              |   |             |  
|Revolving loan payable to a related party                                                                                           |  | $               |            |              | $ | 439,000     |  
|Debt due to an affiliated party                                                                                                     |  |                 |            |              |   | 150,000     |  
|Accounts payable                                                                                                                    |  |                 | 20,825      |              |   | 158,302     |  
|Salaries, wages and payroll taxes                                                                                                   |  |                 | 8,414       |              |   | 7,610       |  
|Other accrued liabilities                                                                                                           |  |                 |            |              |   | 44,080      |  
|Deferred gain on sale of building to a
  related party                                                                              |  |                 |            |              |   | 182,516     |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|TOTAL CURRENT LIABILITIES                                                                                                           |  |                 | 29,239      |              |   | 981,508     |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|STOCKHOLDERS DEFICIT:                                                                                                              |  |                 |             |              |   |             |  
|Common stock, $.05 par value, 12,000,000
  shares authorized, 7,280,306 and 6,713,141 shares issued and outstanding,
  respectively |  |                 | 364,015     |              |   | 335,657     |  
|Additional paid-in capital                                                                                                          |  |                 | 12,622,397  |              |   | 11,883,029  |  
|Accumulated deficit                                                                                                                 |  |                 | (13,010,605 | )            |   | (13,041,419 | )
|                                                                                                                                    |  |                 |             |              |   |             |  
|TOTAL STOCKHOLDERS DEFICIT                                                                                                         |  |                 | (24,193     | )            |   | (822,733    | )
|                                                                                                                                    |  |                 |             |              |   |             |  
|                                                                                                                                    |  |                 |             |              |   |             |  
|TOTAL LIABILITIES AND STOCKHOLDERS
DEFICIT                                                                                         |  | $               | 5,046       |              | $ | 158,775     |  
|                                                                                                                                    |  |                 |             |              |   |             |  

See notes to condensed
financial statements.

Note: The balance sheet as
of June 30, 2005 has been condensed from the audited financial statements.

3

---



DOTRONIX, INC.CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)

|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|------------------------------------------------------------- |  | ------------------------------ | --------- | ---------------------------- | - | --------- | - | ---- | --------- | - | - | --------- | -
|                                                              |  | Three months ended 
  March 31 |           | Nine months ended
  March 31 |  
|                                                              |  |                                |           |                              |  
|                                                              |  | 2006                           |           | 2005                         |   | 2006      |   | 2005 |          
|                                                              |  |                                |           |                              |   |           |   |      |          
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|REVENUES                                                      |  | $                              |          |                              | $ | 109,959   |   | $    | 65,015    |   | $ | 509,697   |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|COST OF SALES                                                 |  |                                |          |                              |   | 99,472    |   |      | 27,531    |   |   | 402,382   |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|GROSS MARGIN                                                  |  |                                |          |                              |   | 10,487    |   |      | 37,484    |   |   | 107,315   |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE                  |  |                                | 12,679    |                              |   | 237,508   |   |      | 205,143   |   |   | 929,467   |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|LOSS FROM OPERATIONS                                          |  |                                | (12,679   | )                            |   | (227,021  | ) |      | (167,659  | ) |   | (822,152  | )
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|OTHER INCOME AND (EXPENSE)                                    |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|Interest expense                                              |  |                                | (5        | )                            |   | (17,664   | ) |      | (6,131    | ) |   | (41,614   | )
|Gain of sale of property and equipment                        |  |                                |          |                              |   |          |   |      | 204,604   |   |   |          |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|                                                              |  |                                | (5        | )                            |   | (17,664   | ) |      | 198,473   |   |   | (41,614   | )
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|NET INCOME (LOSS)                                             |  | $                              | (12,684   | )                            | $ | (244,685  | ) | $    | 30,814    |   | $ | (863,766  | )
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|NET INCOME (LOSS) PER COMMON SHARE- BASIC AND DILUTED         |  | $                              |          |                              | $ | (0.04     | ) | $    |          |   | $ | (0.15     | )
|                                                              |  |                                |           |                              |   |           |   |      |           |   |   |           |  
|AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-BASIC AND
DILUTED |  |                                | 7,276,750 |                              |   | 5,613,734 |   |      | 7,122,342 |   |   | 5,605,975 |  

See notes to condensed financial statements.

4

---



DOTRONIX,
INCCONDENSED STATEMENTS OF CASH FLOWS(UNAUDITED)

|                                                                                                                                                          |  |                            |          |      |   |          |  
|--------------------------------------------------------------------------------------------------------------------------------------------------------- |  | -------------------------- | -------- | ---- | - | -------- | -
|                                                                                                                                                          |  | Nine months ended March 31 |         
|                                                                                                                                                          |  |                            |         
|                                                                                                                                                          |  | 2006                       |          | 2005 |  
|                                                                                                                                                          |  |                            |          |      |  
|CASH FLOWS FROM OPERATING ACTIVITIES:                                                                                                                     |  |                            |          |      |   |          |  
|Net income (loss)                                                                                                                                         |  | $                          | 30,814   |      | $ | (863,766 | )
|Adjustment to reconcile net income (loss)
  to net cash used in operating activities:                                                                     |  |                            |          |      |   |          |  
|Depreciation                                                                                                                                              |  |                            | 6,803    |      |   | 42,013   |  
|Gain on transfer of net assets to a related
  party                                                                                                       |  |                            | (22,088  | )    |   |         |  
|Deferred gain on sale of building                                                                                                                         |  |                            | (182,516 | )    |   | (35,709  | )
|Stock compensation                                                                                                                                        |  |                            |         |      |   | 93,085   |  
|Changes in operating assets and
  liabilities:                                                                                                            |  |                            |          |      |   |          |  
|Accounts receivable                                                                                                                                       |  |                            | 43,654   |      |   | 25,682   |  
|Inventories                                                                                                                                               |  |                            | 8,222    |      |   | 137,460  |  
|Prepaid expenses                                                                                                                                          |  |                            | 18,652   |      |   | 4,118    |  
|Accounts payable and other accrued
  liabilities                                                                                                          |  |                            | 7,068    |      |   | 125,617  |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|NET CASH USED IN OPERATING ACTIVITIES                                                                                                                     |  |                            | (89,391  | )    |   | (471,500 | )
|                                                                                                                                                          |  |                            |          |      |   |          |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|CASH FLOWS FROM INVESTING ACTIVITIES:                                                                                                                     |  |                            |          |      |   |          |  
|Purchases of property and equipment                                                                                                                       |  |                            |         |      |   | (17,093  | )
|Proceeds from sale of property and
  equipment                                                                                                            |  |                            | 1,142    |      |   |         |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|NET CASH PROVIDED BY (USED IN) INVESTING
  ACTIVITIES                                                                                                     |  |                            | 1,142    |      |   | (17,093  | )
|                                                                                                                                                          |  |                            |          |      |   |          |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|CASH FLOWS FROM FINANCING ACTIVITIES:                                                                                                                     |  |                            |          |      |   |          |  
|Borrowings on demand notes                                                                                                                                |  |                            |         |      |   | 269,000  |  
|Borrowings on revolving loan payable to a
  related party                                                                                                 |  |                            | 35,000   |      |   |         |  
|Proceeds from the issuance of common
stock                                                                                                                |  |                            | 40,000   |      |   |         |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|NET CASH PROVIDED BY FINANCING ACTIVITIES                                                                                                                 |  |                            | 75,000   |      |   | 269,000  |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|NET DECREASE IN CASH                                                                                                                                      |  |                            | (13,249  | )    |   | (219,593 | )
|                                                                                                                                                          |  |                            |          |      |   |          |  
|CASH AT BEGINNING OF PERIOD                                                                                                                               |  |                            | 18,295   |      |   | 245,030  |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|CASH AT END OF PERIOD                                                                                                                                     |  | $                          | 5,046    |      | $ | 25,437   |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|                                                                                                                                                          |  |                            |          |      |   |          |  
|SUPPLEMENTAL DISCLOSURES OF NONCASH FINANCING
  ACTIVITIES                                                                                                |  |                            |          |      |   |          |  
|Revolving loan payable to a related party
  and accrued interest converted to 318,246 shares of common stock                                              |  | $                          | 477,369  |      | $ |         |  
|Debt to an affiliated party and accrued
  interest converted to 156,040 shares of common stock                                                            |  |                            | 156,040  |      |   |         |  
|Lease obligation due to an affiliated party
  converted to 66,212 shares of common stock                                                                  |  |                            | 94,317   |      |   |         |  
|Net operating assets transferred to a
  related party for payment of revolving loan (operating assets at fair value
  of $83,700; liabilities of $71,700) |  |                            | 12,000   |      |   |         |  

See notes to condensed financial statements.

5

---



DOTRONIX, INC.NOTES TO CONDENSED FINANCIAL STATEMENTS

A. Basis of
Presentation

The condensed balance sheet as of March 31, 2006, the
condensed statements of operations for the three and nine month periods ended March 31,
2006 and 2005 and the condensed statements of cash flows for the nine
month periods ended March 31, 2006 and 2005 have been prepared by Dotronix,
Inc., (the Company) without audit. In the opinion of management, all
adjustments (consisting only of normal recurring accruals) necessary to present
fairly the financial position, results of operations and cash flows as of March
31, 2006 and for the three and nine month periods ended March 31, 2006 and 2005
presented herein have been made.

Certain information and footnote disclosures normally
included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have been
condensed or omitted. These financial statements should be read in conjunction
with the Companys financial statements and notes thereto included in the
Annual Report on Form 10-KSB of the Company for the fiscal year ended June 30,
2005.

B. Going Concern

The accompanying financial
statements have been prepared assuming the Company will continue as a going
concern. The Company has no current operations and has a working capital
deficiency. Available cash is not sufficient to fund operations beyond a short
period of time. These conditions create uncertainty as to the Companys ability
to continue as a going concern. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.

C. Accounting Policies

The Company believes that
the selection and application of its accounting policies are appropriately
reasoned. The following are the accounting policies that management believes
require the most difficult, subjective or complex judgments about matters that
are inherently uncertain.

Stock Options

Prior to January 1, 2006,
the Company used the accounting guidance of Accounting Principles Board (APB)
Opinion No. 25, Accounting for Stock Issued to Employees, for measurement
and recognition of stock-based transactions with employees. No compensation
cost was recognized for options issued under the plans when the exercise price
of the options is at least equal to the fair market value of the common stock
at the date of grant.

6

---



Statements
of Financial Accounting Standards

Effective January 1, 2006,
the Company adopted the fair value recognition provisions of (SFAS No. 123R) Share-Based
Payment  an amendment of the Financial Accounting Standards Board Statement
No. 123. Among other items, SFAS No. 123R eliminates the use of APB
No. 25 and the intrinsic value method of accounting for stock-based
compensation, and requires companies to recognize in the financial statements
the cost of employee/director services received in exchange for awards of
equity instruments, based on the grant date fair value of those awards. The
Companys options were fully vested as of January 1, 2006, therefore the
adoption of SFAS No. 123R had no impact on the Companys financial statements.
There were no new awards or modifications to existing options during the three
months ended March 31, 2006.

Had compensation cost for
the stock options issued been determined based on the fair value at the grant
date, consistent with the provisions of SFAS No. 123, Accounting for Stock- Based
Compensation, the Companys net loss and net loss per share for the
three and nine months ended March 31, 2005, would not be materially different.

Net Income (Loss) Per
Common Share

Basic net income (loss) per common share is computed
by dividing net income (loss) by the weighted average number of common shares
outstanding. Diluted net income (loss) per common share assumes the exercise of
stock options and warrants using the treasury stock method, if dilutive.

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

The
Company discontinued active business operations in the summer of 2005 and began
seeking one or more business ventures in which to participate. After evaluating
various prospects, during March and April 2006, the Company decided to enter
the business of marketing non-prescription medical products to remedy various
ailments.

Accordingly,
in April 2006 the Company acquired three over-the-counter consumer healthcare
products owned by Russell Mitchell and James Higgins. The purchase price for
these products consisted of 492,121 shares of common stock of the Company
issued to Messrs Mitchell and Higgins. This acquisition was negotiated and
completed by the Company on an arms-length basis, since neither Mr. Mitchell
nor Mr. Higgins had any prior position, ownership or involvement in the
Company. In connection with this acquisition, Messrs Mitchell and Higgins were
elected to serve on the board of directors of the Company. Since the
acquisition, Mr. Mitchell was appointed as the Chief Executive Officer and the
Chief Financial Officer of the Company and Mr. Higgins was appointed as the
Chief Operations Officer of the Company.

The
three products acquired by the Company consist of the following:

7

---



KR-78- A non-prescription canker sore remedy in
the form of a powder contained in a single use applicator providing a
pre-measured dose precisely to the affected area. This product is intended to
reduce the duration and severity of canker sores.

KR-78A  A non-prescription powder remedy for cold
sores applied in a manner similar to KR-78, but having a different formulation
and applicator.

RM-78  A non-prescription smoking cessation aid delivered in a film strip
and intended to help people reduce or eliminate their need to smoke cigarettes.

The Company acquired all
trade secrets, formulas, scientific and manufacturing know-how, trade names,
marketing materials and other intellectual property related to these three
non-prescription products.

The Companys
over-the-counter products will be marketed and branded through a wholly-owned
subsidiary named PuraMed BioScience Inc., which was incorporated in Minnesota
on May 9, 2006.

The Company believes it has
the opportunity to become a significant marketer of non-prescription remedies
developed in-house and sold to consumers in the OTC market, while maintaining
steady growth and profitability. The Company anticipates commercial sales of
its initial three products will commence in the fourth quarter of calendar year
2006. Besides these three products, the Company has several additional product
lines in early stage development.

Each of Mr. Mitchell and
Mr. Higgins each have extensive experience in organizing, developing and
operating successful companies marketing non-prescription drugs and nutritional
supplements. The Company believes their combined experience of over 40 years as
principal executives and founders of companies in this industry will enable us
to leverage their talents and experience to become commercially successful with
good profit margins.

Product
Marketing

All products will initially
be test marketed utilizing print and media advertisements targeting key
metropolitan areas. These cost-effective ads will be designed to sell our
products directly to consumers via toll-free phone numbers and our website, as
well as to refine our consumer message and promote our brand image. Initial
advertising will be followed soon with TV infomercials intended to create
increased consumer awareness while adding a significant revenue stream.

Once we establish our
initial products and PuraMed brand with a substantial consumer base, we will
expand our product distribution into many mainstream retail outlets initially
focusing on drug, food and mass market channels.

After achieving
satisfactory distribution within the retail channels, we intend to initiate a
comprehensive promotional campaign directed toward key consumer groups.

Financial
Condition, Liquidity and Capital Resources

8

---



On
September 12, 2005, a Settlement Agreement and Mutual Release was executed
between the Company and its principal creditor, Terry L. Myhre. Under the terms
of the transaction, Mr. Myhre advanced an additional $35,000 to the Company
under an existing loan agreement established in April 2004, and the parties
terminated the existing loan agreement by converting all debt and accrued
interest owed to Mr. Myhre to common stock of the Company at a conversion price
of $1.50 per share, or a total of 318,246 restricted shares of common stock.
Under the settlement agreement the parties mutually released each other from
all claims arising under the original loan agreement. Mr. Myhre also agreed to
purchase up to 26,667 restricted shares of common stock at $1.50 per share
which he completed by January 2006.

On
September 16, 2005, a Settlement Agreement and Mutual Release was executed
between the Company and the Estate of William S. Sadler whereby the Estate
agreed to convert all debt and accrued interest owed it by the Company to
common stock at a conversion price of $1.00 per share, or a total of 156,040
restricted shares. In addition, the Estate agreed to release all obligations
under a lease between the Estate and the Company for 66,212 restricted shares
of Company common stock. The Company and the Estate mutually released each
other from all further claims.

Two
former officers of the Company, Kurt T. Sadler and Robert V. Kling, formed a
corporation under the name Dotronix Technology, Inc. (DTI). DTI purchased
from Terry Myhre $12,000 of the secured debt owed by the Company to Mr. Myhre.
On September 12, 2005, an agreement was executed between the Company and DTI
whereby DTI acquired
$83,700 of operating assets of the Company and assumed $71,700 of liabilities
in lieu of foreclosure of the security interest held by DTI in the assets of
the Company.

The Company, subsequent to
March 31 has raised $144,800 in working capital. However, there are no existing
understandings, commitments or agreements for an infusion of capital, there are
no assurances to that effect and, if the Company cannot obtain additional
financing, its ability to continue as a going concern is doubtful.

Prior
Operations

During the three month
period ended September 30, 2005, the Company completed the disposition of its
business assets and related operations so that it was no longer engaged in
active business operations at the beginning of the quarter ended December 31,
2005. Consequently, a discussion and comparison of the Companys results of
operations for the three and nine month periods ended March 31, 2006, to the
comparable periods in fiscal year 2005 would not be meaningful.

Forward-Looking Statements

The Private Securities
Litigation Reform Act of 1985 provides a safe harbor for forward-looking
statements made by the Company. All statements, other than statements of
historical fact, which address activities, actions, goals, prospects, or new
developments that we expect or anticipate will or may occur in the future,
including such things as prospects for obtaining additional capital and our
goal of participating in new business ventures and other such matters are
forward-looking statements. Any one or a combination of factors could
materially affect our financial condition and ability to achieve our goal.
These factors include competition

9

---



for business opportunities,
unexpected costs or expenses, legal and regulatory matters, and conditions in
the capital markets. Because of the factors listed above, risk factors
identified in our Annual Report on Form 10-KSB for the year ended June 30, 2005
filed with the Securities and Exchange Commission, and other unknown factors
beyond our control, actual results may differ from those in the forward-looking
statements.

Item 3. CONTROLS AND PROCEDURES

Evaluation of disclosure
controls and procedures.

The Companys Chief Executive and Chief Financial
Officer, Russell W. Mitchell, has reviewed the Companys disclosure controls
and procedures as of the end of the period covered by this report. Based upon
this review, the officer believes that the Companys disclosure controls and
procedures are effective in ensuring that information that is required to be
disclosed by the Company in reports that it files under the Securities Exchange
Act of 1934 is recorded, processed and summarized and reported within the time
periods specified in the rules of the Securities and Exchange Commission.

Changes in internal
controls.

There were no changes in the Companys internal
controls over financial reporting that occurred during the period covered by
this report that have materially affected, or are reasonably likely to
materially affect, the Companys internal control over financial reporting.

PART II - OTHER INFORMATION

Item 5. Other Information

To provide working capital,
during April 2006 the Company sold 230,000 unregistered common shares at $.125
per share for $28,750 to 3 accredited investors (including 60,000 shares to
Craig Laughlin, a former officer and director); and during May 2006 the Company
sold 362,000 unregistered common shares to three accredited investors at $0.40
per share for $144,800. During May 2006, the Company also agreed to issue
25,000 unregistered shares to its legal counsel for legal services performed for
the Company based on $0.40 per share. All of the foregoing sales of common
stock of the Company were made in reliance on the exemption from registration
contained in Section 4 (2) of the Securities Act of 1933, as amended.

Item 6. Exhibits

See Exhibit Index below

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.

|                   |    |  |                         |                     | 
|------------------ | -- |  | ----------------------- | ------------------- | 
|Date: May 12, 2006 |    |  |                         | Dotronix, Inc.     
|                   |    |  |                         |                     | 
|                   | By |  | /s/ Russell W. Mitchell |                    
|                   |    |  |                         |                    
|                   |    |  |                         | Russell W. Mitchell
|                   |    | 

10

---



| |  |  |  |                         | 
| |  |  |  | ----------------------- | 
| |  |  |  | Chief Executive Officer
| |  |  |  | Chief Financial Officer

DOTRONIX, INC.
EXHIBIT INDEX
QUARTERLY REPORT ON FORM 10-QSB
FOR QUARTER ENDED MARCH 31, 2006

| |                   |                                                                           
| | ----------------- | --------------------------------------------------------------------------
| | 21*               | List of Subsidiaries                                                      
| |                   |                                                                           
| | 31.1*             | Certification Pursuant to Section 302 of the
  Sarbanes-Oxley Act of 2002.
| |                   |                                                                           
| | 32.1*             | Certification Pursuant to Section 906 of the
  Sarbanes-Oxley Act of 2002.
| |                   |                                                                           
| | *Filed
  herewith

11

---